These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27037915)

  • 1. Estimation of average causal effect using the restricted mean residual lifetime as effect measure.
    Mansourvar Z; Martinussen T
    Lifetime Data Anal; 2017 Jul; 23(3):426-438. PubMed ID: 27037915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causal inference on the difference of the restricted mean lifetime between two groups.
    Chen PY; Tsiatis AA
    Biometrics; 2001 Dec; 57(4):1030-8. PubMed ID: 11764241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-robust semiparametric estimator for differences in restricted mean lifetimes in observational studies.
    Zhang M; Schaubel DE
    Biometrics; 2012 Dec; 68(4):999-1009. PubMed ID: 22471876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating restricted mean treatment effects with stacked survival models.
    Wey A; Vock DM; Connett J; Rudser K
    Stat Med; 2016 Aug; 35(19):3319-32. PubMed ID: 26934835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating differences in restricted mean lifetime using observational data subject to dependent censoring.
    Zhang M; Schaubel DE
    Biometrics; 2011 Sep; 67(3):740-9. PubMed ID: 21039400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doubly-robust methods for differences in restricted mean lifetimes using pseudo-observations.
    Choi S; Choi T; Lee HY; Han SW; Bandyopadhyay D
    Pharm Stat; 2022 Nov; 21(6):1185-1198. PubMed ID: 35524651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression models for the restricted residual mean life for right-censored and left-truncated data.
    Cortese G; Holmboe SA; Scheike TH
    Stat Med; 2017 May; 36(11):1803-1822. PubMed ID: 28106926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional quantile residual lifetime models for right censored data.
    Lin C; Zhang L; Zhou Y
    Lifetime Data Anal; 2015 Jan; 21(1):75-96. PubMed ID: 24435818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
    Karrison T; Kocherginsky M
    Clin Trials; 2018 Apr; 15(2):178-188. PubMed ID: 29502444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiparametric estimation of proportional mean residual life model in presence of censoring.
    Chen YQ; Jewell NP; Lei X; Cheng SC
    Biometrics; 2005 Mar; 61(1):170-8. PubMed ID: 15737090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Irwin's restricted mean as an index for comparing survival in different treatment groups--interpretation and power considerations.
    Karrison TG
    Control Clin Trials; 1997 Apr; 18(2):151-67. PubMed ID: 9129859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulating survival data with predefined censoring rates for proportional hazards models.
    Wan F
    Stat Med; 2017 Feb; 36(5):838-854. PubMed ID: 27873333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards.
    Díaz I; Colantuoni E; Hanley DF; Rosenblum M
    Lifetime Data Anal; 2019 Jul; 25(3):439-468. PubMed ID: 29492746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of odds of concordance based on the Aalen additive model.
    Martinussen T; Pipper CB
    Lifetime Data Anal; 2013 Jan; 19(1):100-16. PubMed ID: 23104317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A causal proportional hazards estimator under homogeneous or heterogeneous selection in an IV setting.
    Sørensen DN; Martinussen T; Tchetgen Tchetgen E
    Lifetime Data Anal; 2019 Oct; 25(4):639-659. PubMed ID: 31065968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Mizon-Richard encompassing test for the Cox and Aalen additive hazards models.
    Martinussen T; Aalen OO; Scheike TH
    Biometrics; 2008 Mar; 64(1):164-71. PubMed ID: 17608786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On adjustment for auxiliary covariates in additive hazard models for the analysis of randomized experiments.
    Vansteelandt S; Martinussen T; Tchetgen ET
    Biometrika; 2014 Mar; 101(1):237-244. PubMed ID: 28669998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of statistical methods to predict the residual lifetime risk.
    Conner SC; Beiser A; Benjamin EJ; LaValley MP; Larson MG; Trinquart L
    Eur J Epidemiol; 2022 Feb; 37(2):173-194. PubMed ID: 34978669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semiparametric methods to contrast gap time survival functions: Application to repeat kidney transplantation.
    Shu X; Schaubel DE
    Biometrics; 2016 Jun; 72(2):525-34. PubMed ID: 26501480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-estimation of structural nested mean models for competing risks data using pseudo-observations.
    Tanaka S; Brookhart MA; Fine JP
    Biostatistics; 2020 Oct; 21(4):860-875. PubMed ID: 31056651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.